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Muscle sympathetic nerve activity (MSNA) is greatly elevated in patients with obstructive
sleep apnea (OSA) during normoxic daytimewakefulness. IncreasedMSNA is a precursor
to hypertension and elevated cardiovascular morbidity and mortality. However, the
mechanisms underlying the high MSNA in OSA are not well understood. In this study
we used concurrent microneurography and magnetic resonance imaging to explore
MSNA-related brainstem activity changes and anatomical changes in 15 control and
15 OSA subjects before and after 6 and 12 months of continuous positive airway
pressure (CPAP) treatment. We found that following 6 and 12 months of CPAP treatment,
resting MSNA levels were significantly reduced in individuals with OSA. Furthermore, this
MSNA reduction was associated with restoration of MSNA-related brainstem activity and
structural changes in themedullary raphe, rostral ventrolateral medulla, dorsolateral pons,
and ventral midbrain. This restoration occurred after 6 months of CPAP treatment and
was maintained following 12 months CPAP. These findings show that continual CPAP
treatment is an effective long-term treatment for elevated MSNA likely due to its effects
on restoring brainstem structure and function.
Keywords: medullary raphe, dorsolateral pons, sleep disordered breathing, hypertension, rostral ventrolateral
medulla
INTRODUCTION
Obstructive sleep apnea (OSA) is characterized by repetitive complete or partial cessation of
airflow during sleep, owing to collapse of the upper airways. In addition, it has been shown by
numerous investigators that OSA is associated with significantly elevatedmuscle sympathetic nerve
activity (MSNA) during normoxic daytime wakefulness which leads to neurogenic hypertension
(Carlson et al., 1993; Narkiewicz et al., 1998; Lanfranchi and Somers, 2001; Narkiewicz and Somers,
2003). Despite the significant effects of increased MSNA on an individual’s health, the underlying
mechanisms responsible for the increased MSNA in OSA remain unknown.
Over the past decade, numerous investigations have begun to explore the anatomy
and function of the brain in individuals with OSA. These studies have established that
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individuals with OSA display significant gray matter volumetric
changes, primarily gray matter concentration reductions in
numerous higher brain regions, including some that can
significantly modulate changes in MSNA (Macey et al., 2002;
Morrell et al., 2003; Canessa et al., 2011). Furthermore, some
of these studies have shown that OSA is associated with altered
arterial pressure and heart rate responses during numerous
challenges and these altered responses appear to be associated
with alterations in regional brain activity (Harper et al., 2003,
2012; Henderson et al., 2003; Macey et al., 2003, 2006). Although
these studies investigated evoked changes in brain activity during
various cardiovascular challenges, they did not explore brain
sites responsible for the increased resting MSNA and associated
hypertension in individuals with OSA.
In a series of recent studies we have begun to describe
alterations in the neural mechanisms underlying increased
resting MSNA in OSA subjects. Using concurrent recording of
MSNA and functional magnetic resonance imaging (fMRI) of
the brainstem, we found that during each MSNA burst, OSA
subjects displayed significantly lower signal intensity changes in
the region of the medullary raphe, dorsolateral pons (dlPons),
rostral ventrolateral medulla (RVLM), and ventral midbrain
(Lundblad et al., 2014). Remarkably we found that these regions
also displayed increased gray matter concentration in OSA
subjects which was significantly correlated to their elevated
resting MSNA. Furthermore, in a subsequent investigation we
followed these OSA subjects during 6 months of continuous
positive airway pressure (CPAP) treatment and found that along
with a significant reduction in resting MSNA, the functional
and anatomical changes within these brainstem sites returned to
control levels (Lundblad et al., 2015).
The aim of this investigation was to extend this latter
study by investigating whether the functional and anatomical
“restoration” that occurs in OSA subjects after 6 months of
CPAP is maintained during an additional 6 months of CPAP
treatment, or whether the effects seen at 6 months CPAP are
transient in nature. This is important if we are to suggest that
continual CPAP treatment is effective at reducing resting MSNA
and maintaining normal brainstem function. We hypothesized
that the changes in brainstem function and structure observed
following 6 months CPAP would be maintained at similar levels
following an additional 6 months of CPAP treatment.
METHODS
Subjects
Fifteen subjects with obstructive sleep apnea (13 males,
mean ± SEM age 54.0 ± 2.6, range 35–68 years) and 15
healthy controls (12 males, age 50.0 ± 2.9, 35–68 years) were
recruited for the study. All OSA subjects were evaluated and
diagnosed during an overnight sleep study (polysomnography)
at the sleep laboratory of Prince of Wales Hospital. Each
OSA subject was continuously monitored for 8 h using 12-
channel polysomnography: electroencephalogram (EEG),
electrocardiogram (ECG), and submental electromyogram
(EMG) recordings were obtained with surface electrodes.
In addition, nasal and oral airflow were recorded using a
thermistor and chest and abdominal movements were measured
by respiratory inductive plethysmography. Oxyhaemoglobin
saturation measurements were obtained using finger pulse
oximetry and a microphone was placed on the lower neck
to record snoring. Additionally, an ultraviolet light sensitive
camera was used to record patient movements during sleep.
The recorded data was analyzed oﬄine and the presence of
apneas and hypopneas defined according to the international
classification of sleep disorders using Alice (Philips Medical
Systems, The Netherlands) and Somonologica (Medcare
Flaga, Reykjavik, Iceland) software. Based on the full night of
respiratory monitoring, the sleep specialist determined the CPAP
pressure which was necessary to prevent apnoeic events and
subjects were subsequently treated at home with an individually
calibrated CPAP machine (Series 9, ResMed, Sydney, Australia).
CPAP compliance was based on an automated download of the
CPAP machine at 6 and 12 months. Control subjects undertook
an overnight assessment using an in-home device that monitored
nasal airflow and oxygen saturation (ApneaLinkTM; ResMed,
Sydney, Australia). All procedures were approved by the Human
Research Ethics Committees of Western Sydney University
and the University of New South Wales. Written consent was
obtained from all subjects in accordance with the Declaration
of Helsinki. All subjects were included in a series of previous
investigations (Fatouleh et al., 2014, 2015; Lundblad et al., 2014,
2015).
MRI and MSNA Acquisition
In the laboratory, subjects lay supine on a MRI bed with their
knees supported on a foam cushion. An insulated tungsten
microelectrode was inserted precutaneously into amuscle fascicle
of the common peroneal nerve to record multiunit MSNA. An
uninsulated microelectrode was inserted nearby subdermally (1–
2 cm) to act as a reference electrode. Neural activity was amplified
(gain 100, band pass 0.1–5.0 kHz) using a MR compatible
stainless steel isolated headstage (NeuroAmp Ex. ADInstrument,
Australia) and further amplified and filtered (total gain 2 × 104,
band pass 0.3–5.0 kHz). Ag-AgCl surface electrodes were used to
record ECG (0.3-1.0 kHz), radial arterial tonometry (Colin 7000
NIBP, Colin Corp., Aichi, Japan) used to record continuous non-
invasive blood pressure (BP) using and piezoelectric transducer
around the abdomen (Pneumotrace, UFI) to record respiration.
During a 10min period of undisturbed rest, spontaneous MSNA,
heart rate, respiration, and BP were recorded continuously
and the final 5min used for analysis. Following this recording
period, the ECG and BP recordings were stopped and with
the microelectrode in situ, the subject was placed into the
MRI scanner. During the subsequent scanning period, heart
rate was monitored using an MR-compatible piezoelectric
pulse transducer placed on the fingerpad and respiration was
monitored using MR-compatible piezoelectric transducer placed
around the abdomen. All physiology data were recorded using a
computer-based data acquisition and analysis system (PowerLab
16S; ADInstruments, Australia).
With each subject relaxed and enclosed in a 32-channel SENSE
head coil, a continuous series of 200 gradient echo echo-planar
image volumes, each volume covering the entire brainstem from
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the first cervical level to the hypothalamus and sensitive to
Blood Oxygen Level Dependent contrast were collected (46 axial
slices, TR = 8 s, TE = 40ms, flip angle 90◦, raw voxel size =
1.5mm3) using a 3 Tesla MRI whole body scanner (Achieva,
Phillips Medical Systems). A 4 s-ON, 4 s-OFF protocol was used,
with MSNA measured during the initial 4 s-OFF period and all
46 axial images in a single brainstem volume collected during
the subsequent 4 s-ON period. This was repeated a further 199
times so that a total of 200 periods of MSNA interleaved with
200 periods of brainstem fMRI were collected in each subject.
Following this initial scanning session, all 15 OSA subjects began
CPAP treatment as described above and returned for further
MRI scanning sessions 6 and 12 months later. During these
subsequent scanning sessions, T1-weighted anatomical images
were collected from all 15 OSA subjects. Concurrent MSNA and
brainstem fMRI was collected in 11 of these 15 OSA subjects
following both 6 and 12 months of CPAP treatment.
MSNA and fMRI Processing
All MSNA signals were RMS-processed (moving average, time
constant 200ms) andMSNA levels during the pre-MRI recording
period were quantified using time-domain analysis of the RMS-
processed signal. MSNA levels were quantified as both burst
frequency (bursts/min) and burst incidence (bursts/100 heart
beats). Significance differences in MSNA levels across each
group was determined using an analysis of variance, coupled
with Tukey’s multiple comparisons test (GraphPad Prism for
Mac, version 6.0b, USA). Significant differences were determined
between controls and OSA subjects prior to CPAP treatment
using unpaired two-tailed, two-sample t-test, and between OSA
subjects prior to and following 6 and 12 months of CPAP
treatment, repeated measures ANOVAwas performed. All values
quoted are the mean ± SEM and p < 0.05 was used to indicate
significance. During the fMRI scanning period, MSNA bursts
were manually measured from the RMS-processed version of the
filtered nerve signal during the 4-s inter-scan OFF period. This
period was divided into 4 × 1-s intervals, and the total number
of MSNA bursts for each 1-s epoch was determined.
fMRI Processing
With the use of SPM12 software (Friston et al., 1995), brainstem
fMRI images were realigned and coregistered to each subjects
own T1-weighted image set. No subject displayed movement
parameters greater than 1mm in any direction and, as a
result, all subjects were used in the final analysis. Furthermore,
manual correction was performed to create a precise match
with the wholebrain anatomical image set for each subjects.
A linear detrending method was then employed to remove
non-specific global signal intensity drifts and using the SUIT
toolbox (Diedrichsen, 2006), the brainstem and cerebellum were
isolated from the wholebrain and the fMRI images spatially
normalized into Montreal Neurological Institute (MNI) space
using a spatially unbiased atlas template. The fMRI images were
then spatially smoothed using a 3mm full-width half-maximum
Gaussian filter.
For each of the 200 fMRI image volumes, the 4 s during
which brainstem BOLD signals were recorded were related to
the MSNA burst in the preceding 4-s period. This is possible
because (1) the delay in neurovascular coupling mean that BOLD
signal intensity changes lag neuronal events by ∼5 s (Logothetis
et al., 2001), and (2) slow conduction speeds of unmyelinated
peripheral axons means it requires ∼1 s for a sympathetic burst
to be transmitted from the brain to the peripheral recording
site (Fagius and Wallin, 1980); as a consequence of these two
factors, it is apparent that (3) a BOLD signal intensity change
would occur∼4 s after an increase in neuronal activity within the
brain. Furthermore, since we collected brain images in a caudal-
to-rostral direction, we could target specific brainstem regions
given the timing relationship between scanning acquisition and
structure (Figure 1). Thus, for each subject, the brainstem was
divided into four sections from caudal to rostral corresponding to
the first, second, third, and fourth 1-s periods and a brain mask
was created for each of these 1 s periods. The fourth 1-s period
was discarded as it covered the region rostral to the brainstem.
TheMSNA recordings were also then divided into corresponding
1-s periods.
For each 1-s epoch, a “1” was entered into an fMRI search
model if a MSNA burst occurred and a “0” if no burst
occurred. This process was repeated resulting in a 200-volume
fMRI search model for each of the 3 × 1-s periods. Figure 1
shows an example of a MSNA burst model created using this
procedure. A general linear model approach was then used
to determine changes in BOLD signal intensity that matched
each individual subject’s MSNA burst model for each of the 1-
s epochs. Since we had accounted for the hemodynamic delay
in our methodological setup, the hemodynamic delay function
and microtime resolution were removed from the analysis.
Additionally, for each subject, their six directional movement
parameters derived from the realignment step were added as
nuisance variables. We also included signal changes derived from
a 2-mm sphere placed in the center of the fourth ventricle as a
nuisance variable, in an attempt to eliminate the effects of heart
rate.
We used second level analyses to compare signal intensity
changes during each MSNA burst in OSA subjects prior to
CPAP and following 6 and 12 months of CPAP treatment. Any
significant difference in MSNA-related signal intensity change
in each individual subject over the three time points (pre-
CPAP, 6 months CPAP, 12 months CPAP) were determined
using an F test and the results displayed using a threshold
of p < 0.005 uncorrected for multiple comparisons. During
this second-level analysis, the resulting statistical maps were
masked with the brain or brainstem region corresponding to
the relevant 1-s epochs. We have previously explored brainstem
functional and anatomical changes in 13 OSA subjects following
6 months CPAP treatment (Lundblad et al., 2014, 2015) and
11 of these OSA subjects returned following 12 months CPAP
treatment for this investigation. Furthermore, the 15 OSA and
15 control subjects in which T1-weighted anatomical images
were used to explore changes in gray matter concentration were
also used in previous investigations (Fatouleh et al., 2014, 2015;
Lundblad et al., 2014, 2015). Given that this study is essentially
an extension of this earlier investigation and we hypothesized
that CPAP treatment would result in signal change restoration
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FIGURE 1 | Upper panel shows a typical microneurographic recording in an individual subject during concurrent functional magnetic resonance
imaging (fMRI). Brainstem images were collected during a 4 s at which time muscle sympathetic nerve activity (MSNA) activity was not distinguishable. However, due
to the fMRI haemodynamic delay (∼5 s) and the delay for MSNA traffic to travel from the brain to the recording electrode (∼1 s), brain activity during the MSNA
collection period was reflected in signal intensity changes during the subsequent 4 s period. The vertical gray shading represents a 1 s period of MSNA recording and
the associated 1 s period of fMRI image collection. During each 1 s epoch of the collection period (4 s), if a MSNA burst occurred, a “1” was entered into an fMRI
search model (lower left panel). This was repeated for each of the 200 fMRI volumes to create a 200 point fMRI model. The MSNA burst in the above recording is
entered into the fMRI search model (vertical gray bar). The MSNA burst that occurred during the 2nd second of the collection period arose during collection of fMRI
images through the rostral medulla and pons. This brainstem region is represented by the gray horizontal shading on a sagittal section of an individual’s fMRI images
set (lower right panel). RMS: root mean square. This figure is modified from our previous publication (Fatouleh et al., 2015).
and maintenance in regions we previously showed to change
following 6 months CPAP, we employed small volume correction
for multiple comparisons (p < 0.05).
It is possible that differences in activation patterns were
partially due to differences in the number of MSNA bursts in
controls compared to OSA subjects since we were correlating
ongoing signal intensity fluctuations with spontaneous MSNA
fluctuations. That is, differences in the number of ON and
OFF periods could influence the overall significance of the final
contrast maps, which in turn may have influenced the second-
level analyses. To reduce this possibility, for each significant
group of three or more contiguous voxels that survived the
statistical threshold (significant cluster), we extracted the raw
signal intensity changes in OSA subjects before and after
CPAP treatment, as well as in control subjects, and compared
signal intensity during bursts of MSNA to signal intensity
during periods where there were no bursts. For each significant
cluster, the mean (±SEM) signal intensity changes for each
group were plotted. Significant differences in signal intensity
between controls and OSA subjects (two-sample t-test, p <
0.05) and significant differences in OSA subjects before and
following 6 and 12 months CPAP treatment were determined
(two-tailed, paired t-test, p < 0.05). Finally, for each significantly
different cluster, linear relationships between AHI-values and the
difference in fMRI signal intensity change pre-CPAP compared
with the mean of the control subjects and in OSA subjects
pre-CPAP compared with 6 and 12 months post-CPAP were
determined (p < 0.05).
T1 Image Processing
Using the SUIT toolbox, the wholebrain images were cropped and
the brainstem masked to remove all supratentorial gray matter.
The brainstem images were then spatially normalized with a
dedicated symmetrical brainstem template, spatially normalized
into the brainstem template space and modulated by the volume
changes due to the normalization. Finally, the resulting “maps”
of gray matter probabilities were smoothed using a 3mm
full-width half-maximum Gaussian filter. Second-level random-
effects analyses were performed to compare gray matter volume
(concentration) changes in OSA subjects prior to CPAP and
following 6 and 12 months of CPAP treatment. Any significant
change in gray matter volume in each individual subject over the
three time points (pre-CPAP, 6 months CPAP, 12 months CPAP)
were determined using an F test and the results displayed using a
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threshold of p < 0.05 false discovery rate corrected for multiple
comparisons. For each significant cluster, gray matter volumes
were extracted in OSA subject’s pre-CPAP, 6 months CPAP and
12 months CPAP as well as from controls and the mean (±SEM)
plotted. Significant differences in gray matter volume between
controls and OSA subjects (two-sample t-test, p < 0.05) were
determined. Finally, for each significantly different cluster, linear
relationships between AHI-values and the difference in gray
matter volume pre-CPAP compared with the mean of the control
subjects and in OSA subject’s pre-CPAP compared with 6 and 12
months post-CPAP were determined (p < 0.05).
RESULTS
OSA Subject Characteristics
Although, all OSA and control subjects were included in a series
of previous investigations and thus some of the diagnostic results
have been published previously, we have included them in this
manuscript for completeness. OSA subjects were diagnosed on
the basis of their apnea-hypopnea index (AHI)-values (apnea-
hypopnea events per hour) as mild, moderate, or severe (mild:
AHI 5–15; moderate: AHI 15–30; severe: AHI > 30). Of the 15
OSA subjects, 2 subjects had mild OSA, 1 subject had moderate
OSA, and 12 subjects had severe OSA (AHI 37.2 ± 4.1; range 7–
62). The minimum SaO2 during sleep was 82.7 ± 2.0% (range
67–93%); the baseline SaO2 during wakefulness was 94.9 ± 0.7%
(range 91–99%), and the Baseline Epworth Sleep Scale score was
8.6 ± 1.2 (range 3–19). We found that OSA patients used CPAP
for an average of 5.5 ± 0.3 h/night during the first 6 month
period and 5.5 ± 0.3 h/night during the 6–12 month period
and there was a significant reduction in AHI after 6 months of
CPAP treatment (AHI 3.0 ± 0.8; range 0.6–9.9) which reduced
further after 12 months treatment (AHI 1.6 ± 0.4; range 0.3–
7.1). Although, the mean AHI for control subjects was only
3.0 ± 1.0, we did find that two of the control subjects had an
AHI of 8 and 10. We did not exclude these subjects since they
were asymptomatic normotensive and did not report being tired
during the day or snoring during sleep; we did not consider it
necessary to undertake a full polysomnographic assessment in
these two subjects. There was no difference in age between OSA
and control groups (two-sample t-test; p > 0.05) and although
OSA subjects had greater body mass index than controls during
the first MRI session (BMI: pre-CPAP 31.3± 1.5, controls 25.1±
1.1; p = 0.0014), their BMI did not alter between MRI scanning
sessions [pre-CPAP: 31.3 ± 1.5; 6 months CPAP 31.5 ± 1.9; 12
months CPAP: 31.0 ± 3.1; p > 0.05; F(2,30) = 0.0159; p =
0.9842].
Physiology
During the laboratory recording session, compared with
controls, OSA subjects (n = 15) had significantly elevated
systolic (controls vs. OSA: 121.4 ± 4.0 vs. 137.7 ± 4.9mmHg;
p = 0.04) and diastolic (67.9 ± 3.6 vs. 80.6 ± 2.1mmHg;
p = 0.004) pressures before CPAP. Furthermore, MSNA burst
frequency (24.2 ± 2.4 vs. 54.2 ± 3.1 bursts/min; p < 0.0001)
and burst incidence (37.7 ± 3.2 vs. 79.0 ± 5.7 bursts/100
heart beats; p < 0.0001) were both significantly elevated in
OSA subjects compared with controls before CPAP. Repeated-
measures analysis of variance revealed significant change in burst
frequency and burst incident at 0 (baseline), 6 and 12 months
of compliant CPAP use. Six months of CPAP treatment resulted
in on average, a significant reduction in resting MSNA which
was maintained at 12 months CPAP treatment [burst frequency:
pre-CPAP: 54.2 ± 3.1; 6 months CPAP: 37.9 ± 2.0; 12 months
CPAP: 38.0 ± 2.4; F(1.552, 21.73) = 18.14; p < 0.0001; burst
incidence: pre-CPAP: 79.0 ± 5.7; 6 months CPAP: 56.9 ± 3.2; 12
months CPAP: 49.4 ± 2.2; F(2,38) = 16.55; p < 0.0001]. Figure 2
shows physiology recordings from one OSA subject pre-CPAP,
following 6 months and 12 months of CPAP treatment during
their three fMRI scanning sessions. It is clear that CPAP results
in a reduction in the number of MSNA bursts during each fMRI
scanning period. Consistent with the lab sessions, the reduction
in MSNA resulting from CPAP treatment was also evident
FIGURE 2 | Multiunit recording of muscle sympathetic nerve activity
(MSNA) from a 50-year-old male patient with obstructive sleep apnea
(OSA) acquired during functional magnetic resonance imaging
sessions prior to, following 6 months and following 12 months of
continuous positive airway pressure (CPAP) treatment. Each recording
shows four consecutive sets of the 4s-ON and 4s-OFF scanning sequences;
the black areas represent the scanning artifacts. MSNA burst amplitudes were
measured during the OFF periods. The mean-voltage neurogram is shown in
the nerve RMS (root mean square) trace; this was used to quantify the number
of sympathetic bursts. Note the high number of MSNA bursts (identified by *)
pre-CPAP which is reduced following 6 and 12 months of CPAP treatment.
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FIGURE 3 | Plots of muscle sympathetic nerve activity (MSNA) during the laboratory session and the brainstem functional magnetic resonance
imaging (fMRI) session in controls and in individuals with obstructive sleep apnea (OSA) prior to and following 6 and 12 months of continuous positive
airway pressure (CPAP) treatment. Individual values of bursts/min for the laboratory session and total MSNA bursts during the fMRI session are represented by the
open circles. Note that CPAP results in a reduction in resting MSNA toward control levels.
FIGURE 4 | Brainstem regions in which fMRI signal intensity changes correlated to muscle sympathetic nerve activity (MSNA) were significantly
altered by continuous positive airway pressure (CPAP) treatment over 12 months in subjects with obstructive sleep apnea (OSA). Hot color scale
indicates brainstem regions in which signal intensity (SI) changes were significantly altered by CPAP treatment. Significant clusters are overlaid onto a T1-weighted
anatomical template image. Slice location in Montreal Neurological Institute space are indicated at the upper right of each image. The lower panel shows plots of
mean (±SEM) percentage changes in signal intensity during each MSNA burst compared to periods of no MSNA bursts for each significant cluster in controls and
OSA subjects prior to and following 6 and 12 months of CPAP treatment. Significant difference were determined using two-sample and paired t-tests (*p < 0.05).
dlPons, dorsolateral pons; RVLM, rostral ventrolateral medulla. Note that for most brainstem regions, CPAP treatment restores brainstem function to control levels.
during the fMRI sessions in the 11 OSA subjects that completed
this part of the experiment (total bursts during brainstem fMRI
scan: controls: 151 ± 24; pre-CPAP: 350 ± 37; 6 months CPAP:
167± 33; 12 months CPAP: 182± 21; Figure 3).
Brainstem fMRI Signal Intensity Changes
MSNA-related BOLD signal intensity changes pre-CPAP and
following 6 and 12 months CPAP revealed significant changes
in MSNA-related signal intensity changes in a numerous
brainstem regions (Figure 4). Significantly signal intensity
changes occurred in the region of the caudal medullary raphe, left
and right rostral medulla in the region of the rostral ventrolateral
medulla (RVLM), left and right dorsolateral pons (dlPons) in the
region of the parabrachial nucleus and in the ventral midbrain
in the region of the ventral tegmental area. Comparison of
percentage changes in signal intensity during MSNA bursts,
compared with periods of no bursts, showed that CPAP restored
brainstem activity to control levels in most of these regions.
Within the medullary raphe, RVLM, left and right dlPons,
MSNA-related signal intensity was reduced pre-CPAP compared
to controls but then increased to control levels following CPAP
treatment (see Table 1 for mean signal intensity changes). The
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TABLE 1 | Locations and mean signal intensity changes in muscle sympathetic nerve (MSNA) related changes in blood oxygen level dependent signal
intensity in controls and subjects with obstructive sleep apnea (OSA) prior and following 6 and 12 months of continuous positive airway pressure (CPAP)
treatment.
Brainstem region MNI co-ordinate Cluster size F-score Mean (±SEM) signal intensity change
x y z Controls OSA pre-CPAP OSA 6m CPAP OSA 12m CPAP
Medullary raphe 2 −40 −58 11 5.90 0.16 ± 0.13 −0.12 ± 0.09* 0.22 ± 0.11† 0.10 ± 0.10
RVLM
Left −4 −36 −44 6 4.14 0.16 ± 0.07 −0.07 ± 0.07* 0.06 ± 0.06† 0.05 ± 0.06
Right 10 −44 −48 6 7.20 0.12 ± 0.08 −0.08 ± 0.06* −0.18 ± 0.09*† 0.08 ± 0.07‡
dlPons
Left −2 −30 −22 51 12.31 0.16 ± 0.06 −0.02 ± 0.09* 0.34 ± 0.17† 0.18 ± 0.11
Right 4 −38 −32 5 4.08 0.37 ± 0.15 0.08 ± 0.08* 0.12 ± 0.06 0.53 ± 0.14†‡
8 −34 −24 7 2.90
Ventral midbrain 0 −22 −14 16 2.78 −0.01 ± 0.05 −0.39 ± 0.14* 0.30 ± 0.18*† 0.19 ± 0.11*†
Locations are given in Montreal Neurological Institute space.
*Significantly different to controls.
†
Significantly different to OSA pre-CPAP.
‡
Significantly different to OSA 6 months CPAP (p < 0.05).
dlPons, dorsolateral pons; RVLM, rostral ventrolateral medulla.
ventral midbrain was also significantly reduced in OSA subjects
pre-CPAP compared with controls and although CPAP treatment
reversed this decrease it resulted in an increase that remained
above control levels following CPAP treatment. Finally, signal
intensity changes pre-CPAP compared with controls or in OSA
following 6 and 12 months of CPAP treatment in all of these
brainstem regions were not significantly correlated to individual
subject’s OSA severity (raphe: 0 m: r = 0.11, p = 0.75, 6 m:
r = 0.02, p = 0.96, 12 m: r = 0.32, p = 0.33; left RVLM: 0
m: r = 0.19, p = 0.58, 6 m: r = 0.21, p = 0.54, 12 m: r = 0.12,
p = 0.73; right dlPons: 0 m: r = 0.01, p = 0.99, 6 m: r = 0.04,
p = 0.91, 12 m: r = 0.18, p = 0.61; left dlPons: 0 m: r = 0.37,
p = 0.26, 6 m: r = 0.20, p = 0.55, 12 m: r = 0.44, p = 0.18;
ventral midbrain: 0 m: r = 0.11, p = 0.75, 6 m: r = 0.23,
p = 0.50, 12 m: r = 0.19, p = 0.58).
Brainstem Gray Matter Concentration
Changes
Comparison of gray matter concentrations resulted in a
remarkably similar set of brainstem structures to those displaying
functional differences. Gray matter concentration increases in
OSA subjects pre-CPAP compared with controls occurred in
the medullary raphe, the region encompassing the RVLM, the
dlPons and in the ventral midbrain (Figure 5). As with the
functional changes, within all of these regions, gray matter
concentration was returned to levels not different to controls
following 12 months of CPAP treatment (see Table 2 for gray
matter concentrations). Within the medullary raphe and ventral
midbrain, gray matter concentration following 6 months CPAP
rebounded to levels marginally below control levels before
returning to levels not different to controls following 12 months
CPAP.Within the left RVLM and dlPons, gray matter returned to
control levels after 6 months CPAP and then remained at control
levels following 12 months CPAP. Similar to the fMRI signal
changes, gray matter concentration changes pre-CPAP compared
with controls or in OSA following 6 and 12 months of CPAP
treatment in all of these brainstem regions were not significantly
correlated to individual subject’s OSA severity (raphe/RVLM:
0m: r = 0.10, p = 0.71, 6m: r = 0.04, p = 0.89, 12m:
r = 0.12, p = 0.66; left RVLM: 0m: r = 0.25, p = 0.36,
6m: r = 0.28, p = 0.30, 12m: r = 0.31, p = 0.26; right dlPons:
0m: r = 0.20, p = 0.49, 6m: r = 0.23, p = 0.40, 12m: r = 0.03,
p = 0.92; left dlPons: 0m: r = 0.09, p = 0.76, 6m: r = 0.11, p =
0.70, 12m: r = 0.18, p = 0.52; ventral midbrain: 0m: r = 0.10,
p = 0.73, 6m: r = 0.06, p = 0.83, 12m: r = 0.07, p = 0.81).
DISCUSSION
We found that the increase in resting MSNA in individuals
with OSA was significantly reduced toward control levels
following 6 and 12 months of CPAP treatment. This MSNA
reduction was associated with restoration of MSNA-related
activity and structural changes in the medullary raphe, RVLM,
dlPons and ventral midbrain. This restoration occurred after
6 months of CPAP treatment and was maintained following
12 months CPAP. These findings show that continual CPAP
treatment is an effective long-term treatment for elevated MSNA
likely due to its effects on restoring brainstem structure and
function.
We and others have shown that the elevated MSNA associated
with OSA is significantly reduced by CPAP treatment (Hedner
et al., 1988; Narkiewicz et al., 1999a; Fatouleh et al., 2015;
Lundblad et al., 2015). Interestingly, we found that during
the fMRI sessions, during the first 6 months of CPAP, MSNA
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FIGURE 5 | Brainstem regions in which gray matter (GM) concentrations were significantly altered by continuous positive airway pressure (CPAP)
treatment over 12 months in subjects with obstructive sleep apnea (OSA). Hot color scale indicates brainstem regions in which gray matter concentration
changes were significantly altered by CPAP treatment. Significant clusters are overlaid onto a T1-weighted anatomical template image. Slice location in Montreal
Neurological Institute space are indicated at the upper right of each image. The lower panel shows plots of mean (±SEM) gray matter concentrations for each
significant cluster in controls and OSA subjects prior to and following 6 and 12 months of CPAP treatment. Significant difference were determined using two-sample
and paired t-tests (*p < 0.05). dlPons, dorsolateral pons; RVLM, rostral ventrolateral medulla. Note that for most brainstem regions, CPAP treatment restores
brainstem anatomy to control levels.
TABLE 2 | Locations of gray matter concentration differences in controls compared with subjects with obstructive sleep apnea (OSA) prior and following
6 and 12 months of continuous positive airway pressure (CPAP) treatment.
Brainstem region MNI co-ordinate Cluster size F-score Mean (±SEM) signal intensity change
x y z controls OSA pre-CPAP OSA 6m CPAP OSA 12m CPAP
Raphe/Right RVLM 2 −34 −47 187 12.95 0.24 ± 0.02 0.31 ± 0.02* 0.16 ± 0.02*† 0.23 ± 0.02‡‡
6 −38 −46
Left RVLM −5 −39 −46 10 10.16 0.24 ± 0.02 0.31 ± 0.03* 0.20 ± 0.02† 0.25 ± 0.02‡‡
dlPons
Left 13 −39 −37 852 57.38 0.14 ± 0.02 0.19 ± 0.02* 0.09 ± 0.01*† 0.08 ± 0.01*†
Right −10 −32 −33 50 22.15 0.16 ± 0.02 0.22 ± 0.02* 0.12 ± 0.01† 0.12 ± 0.01†
Ventral midbrain −2 −27 −18 120 26.56 0.17 ± 0.02 0.21 ± 0.02 0.13 ± 0.01*† 0.14 ± 0.01†‡
Locations are given in Montreal Neurological Institute space.
*Significantly different to controls.
†
Significantly different to OSA pre-CPAP.
‡
Significantly different to OSA 6 months CPAP (p<0.05).
dlPons, dorsolateral pons; RVLM, rostral ventrolateral medulla.
decreased dramatically and was maintained at these lower
levels. Associated with the reduction in MSNA were significant
functional changes in a number of brainstem regions including
the medullary raphe, RVLM, dlPons, and ventral midbrain. In
these regions, signal intensity was significantly reduced in OSA
subjects pre-CPAP compared to controls, but returned to or
increased above control levels following 6 months CPAP and
remained at these levels at the 12 month CPAP scan. It is well-
established that the RVLM contains premotor neurons which
project directly to the sympathetic preganglionic neurons in
the intermediolateral cell column of the spinal cord (Dampney,
1994) and human imaging studies support its role in mediating
evoked changes in sympathetic drive and resting sympathetic
activity (Macefield et al., 2006; Macefield and Henderson, 2010;
Sander et al., 2010). Brainstem sites such as the medullary
raphe and dlPons can mediate MSNA changes via their direct
projections to the RVLM (Saper and Loewy, 1980; Carrive et al.,
1988; Lovick, 1992) although the medullary raphe also projects
directly to the intermediolateral cell column (Loewy, 1981).
Surprisingly, despite elevated MSNA, OSA subjects displayed
decreases in MSNA-related signal intensity within the RVLM
which subsequently increased during CPAP treatment. These
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signal changes appear at odds with the finding that OSA is
associated with elevated MSNA and our previous report that
RVLM signal intensity increases during each MSNA burst in
healthy controls (Macefield and Henderson, 2010). Furthermore,
the chronic intermittent hypoxia (CIH) model of OSA which is
characterized by chronically elevated sympathetic activity and
increased arterial pressure (Fletcher et al., 1992; Bao et al.,
1997) is also associated with increased neural activity in the
RVLM (Greenberg et al., 1999; Knight et al., 2011). It is possible
that the decrease in RVLM signal intensity in OSA subjects
reflects altered drive from the raphe, dlPons and/or the ventral
midbrain. Indeed, reduced inhibitory drive onto the RVLM from
these other brainstem sites would likely result decreased signal
intensity but increased RVLM output onto the preganglionic
sympathetic neurons in the intermediolateral cell column.
OSA subjects also displayed signal decreases within the
medullary raphe, dlPons and ventral midbrain that returned
to control levels at 6 months CPAP and remained at control
levels at 12 months CPAP. Although in experimental animals
CIH does not increase dlPons resting activity, it does result in
altered reactivity with enhanced activity during acute stressors
(Ma et al., 2008). While inactivation of the either the dlPons
or the medullary raphe does not alter resting arterial pressure
and heart rate (Henderson et al., 2000; Shafei et al., 2011),
chemical stimulation can evoke increases or decreases in arterial
pressure, and sympathetic nerve activity (Hade et al., 1988;
Miyawaki et al., 1991; Dampney, 1994; Coleman and Dampney,
1995; Henderson et al., 1998). The cardiovascular responses
to medullary raphe stimulation appear to be mediated via
projections to the RVLM since bilateral micro-injections of
bicuculline into RVLM sympathoexcitatory sites abolishes the
depressor and sympathoinhibitory response evoked bymedullary
raphe stimulation (Coleman and Dampney, 1998). Similarly,
the dlPons can alter cardiovascular function via the RVLM
since stimulation of the parabrachial nucleus in the dlPons
increases glutamate release in the RVLM and supresses baroreflex
bradycardia (Len and Chan, 1999). A clear role for the ventral
midbrain in autonomic function is less clear although substance
P injections into the ventral tegmental area can evoke increases in
blood pressure and heart rate (Cornish and van den Buuse, 1995)
and neurotensin injections potentiate the pressor response to
intravenous vasopressin (van Den Buuse and Catanzariti, 2000).
Though unlike the medullary raphe and dlPons, a direct effect on
RVLM activity and MSNA by the ventral midbrain remains to be
established.
In addition to functional alterations, the dlPons, RVLM,
medullary raphe and ventral midbrain displayed increased gray
matter volumes in OSA subjects pre-CPAP compared with
controls with this altered anatomy returning to baseline levels
during CPAP treatment. Although it is not possible in this
investigation to determine the precise cellular changes that may
have resulted in these increases in gray matter volume, numerous
investigations have explored gray matter changes in OSA and
found decreases in several regions such as in the hippocampus,
cingulate, cerebellar, and prefrontal cortices (Macey et al., 2002;
Morrell et al., 2003; Canessa et al., 2011). It has been proposed
that these volume decreases result from the repeated hypoxic
damage that results from extended periods of night-time apneas
and hypoxaemia. However, in striking contrast to changes in
higher brain centers, we found that within the brainstem, OSA
subjects had increased gray matter volumes. It is well known
that increased use is associated with increases in gray matter
volume in relevant brain regions (Amunts et al., 1997; Maguire
et al., 2000; Sluming et al., 2002), although we suggest that
“over-use” changes are less likely in the brainstem due to its
already tonic nature. Furthermore, we found that neither the
anatomical and functional changes pre-CPAP nor the recovery
of these values during 6 and 12 months of CPAP treatment were
correlated to an individual’s OSA severity. These results suggest
that the anatomical and functional changes that occur within the
brainstem of OSA subjects may not be directly related to the
severity of OSA but instead may occur to a maximal extent even
in individuals with less severe levels of OSA.
Despite the clear role for the raphe and dlPons in autonomic
regulation, our functional and structural findings raise an
important question: how do functional and structural changes
within the brainstem start? Although we do not have direct
evidence, we speculate that these changes are consistent with
a mechanism involving astrocytic activation and modulation
of synaptic activity through altered gliotransmission. It has
recently been reported that the CIH model of OSA is associated
with significant astrocyte activation in cortical areas such as
the hippocampus and further this astrocyte activation is not
associated with significant neural death (Aviles-Reyes et al.,
2010). It is possible that astrocyte activation also occurs in
the raphe, dlPons, and ventral midbrain in individuals with
OSA which is consistent with increased gray matter volumes.
Astrocyte activation can result in a significant alteration of
synaptic dynamics (Halassa et al., 2007; Ben Achour and Pascual,
2012) and are involved in brainstem rhythmic activity since
astrocytic glutamate toxins reduce inspiratory burst frequency
(Hulsmann et al., 2000). It is possible that a similar modulatory
effect of glia might also occur in sympathetic regulatory
regions and that continuous hypoxia events result in astrocyte
activation which in turn results in altered local synaptic
dynamics.
Limitations
There are a number of limitations to this study which require
consideration. We did not follow control subjects over a 12
month period to examine reproducibility of the MSNA, fMRI
or gray matter concentration measurements and we did not
include OSA subjects that did not undergo CPAP treatment.
Although with respect to MSNA, others have shown no change
in OSA patients who did not receive CPAP when followed
up over a year (Narkiewicz et al., 1999b). Very few brain
imaging investigations have explored human brainstem structure
and function, particularly in a longitudinal manner, however
given that in almost all brainstem regions displaying an initial
difference between controls and OSA subjects, signal intensity
and gray matter concentrations recovered to control levels
following 6 months of CPAP treatment and remained relatively
stable for the next 6 months, we are confident that the changes
reported here are indeed reliable. Further, one must be careful
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when describing the location of significant clusters in any human
brain imaging investigation. Particularly within the brainstem,
given the limited spatial resolution of brainstem imaging it is
impossible to be completely sure that the significant clusters
represent for example the RVLM. However, we contend that they
are located in the described regions and given what is known
about the roles of such regions in modulating sympathetic drive,
it is likely that our descriptions are accurate. We are not able to
determine differences in constant neural activity between subject
groups but instead we are restricted to assessing MSNA related
changes in activity. It might be the case that a particular cortical
region is constantly driving brainstem sites such as the RVLM
and dlPons which could be assessed in future studies using a
technique such as arterial spinal labeling. Finally, although we
found no relationship between OSA severity and either fMRI
signal intensity or gray matter volume changes, the inclusion of
more subjects, particularly with mild OSA, would be required to
make this conclusion reliable.
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